Does the media prefer HSIC or EW?

In the previous week, Edwards Lifesciences had 7 more articles in the media than Henry Schein. MarketBeat recorded 23 mentions for Edwards Lifesciences and 16 mentions for Henry Schein. Edwards Lifesciences' average media sentiment score of 1.25 beat Henry Schein's score of 0.58 indicating that Edwards Lifesciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Henry Schein 4 Very Positive mention(s) 1 Positive mention(s) 9 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Edwards Lifesciences 18 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer AMN or EW?

In the previous week, Edwards Lifesciences had 14 more articles in the media than AMN Healthcare Services. MarketBeat recorded 23 mentions for Edwards Lifesciences and 9 mentions for AMN Healthcare Services. Edwards Lifesciences' average media sentiment score of 1.25 beat AMN Healthcare Services' score of 0.83 indicating that Edwards Lifesciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AMN Healthcare Services 5 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Edwards Lifesciences 18 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer ABT or EW?

In the previous week, Abbott Laboratories had 31 more articles in the media than Edwards Lifesciences. MarketBeat recorded 54 mentions for Abbott Laboratories and 23 mentions for Edwards Lifesciences. Edwards Lifesciences' average media sentiment score of 1.25 beat Abbott Laboratories' score of 1.11 indicating that Edwards Lifesciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Abbott Laboratories 36 Very Positive mention(s) 5 Positive mention(s) 5 Neutral mention(s) 4 Negative mention(s) 1 Very Negative mention(s) Positive Edwards Lifesciences 18 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer SYK or EW?

In the previous week, Stryker had 35 more articles in the media than Edwards Lifesciences. MarketBeat recorded 58 mentions for Stryker and 23 mentions for Edwards Lifesciences. Edwards Lifesciences' average media sentiment score of 1.25 beat Stryker's score of 0.90 indicating that Edwards Lifesciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Stryker 28 Very Positive mention(s) 8 Positive mention(s) 15 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Edwards Lifesciences 18 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to EW or ISRG?

In the previous week, Intuitive Surgical had 28 more articles in the media than Edwards Lifesciences. MarketBeat recorded 51 mentions for Intuitive Surgical and 23 mentions for Edwards Lifesciences. Edwards Lifesciences' average media sentiment score of 1.25 beat Intuitive Surgical's score of 1.05 indicating that Edwards Lifesciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Edwards Lifesciences 18 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Intuitive Surgical 37 Very Positive mention(s) 1 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive

Edwards Lifesciences (EW) Competitors

$86.17 -0.75 (-0.86%)

Closing price 07/31/2026 03:59 PM Eastern

Extended Trading

$86.76 +0.58 (+0.68%)

As of 07/31/2026 07:34 PM Eastern

Compare

EW vs. HSIC, AMN, ABT, SYK, and ISRG

Should you buy Edwards Lifesciences stock or one of its competitors? MarketBeat compares Edwards Lifesciences with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Edwards Lifesciences include Henry Schein (HSIC), AMN Healthcare Services (AMN), Abbott Laboratories (ABT), Stryker (SYK), and Intuitive Surgical (ISRG).

How does Edwards Lifesciences compare to Henry Schein?

Henry Schein (NASDAQ:HSIC) and Edwards Lifesciences (NYSE:EW) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, dividends, media sentiment, institutional ownership, profitability, valuation and earnings.

Henry Schein currently has a consensus target price of $89.36, suggesting a potential upside of 4.21%. Edwards Lifesciences has a consensus target price of $100.27, suggesting a potential upside of 16.36%. Given Edwards Lifesciences' stronger consensus rating and higher possible upside, analysts plainly believe Edwards Lifesciences is more favorable than Henry Schein.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Henry Schein	1 Sell rating(s)	6 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.47
Edwards Lifesciences	0 Sell rating(s)	6 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.74

In the previous week, Edwards Lifesciences had 7 more articles in the media than Henry Schein. MarketBeat recorded 23 mentions for Edwards Lifesciences and 16 mentions for Henry Schein. Edwards Lifesciences' average media sentiment score of 1.25 beat Henry Schein's score of 0.58 indicating that Edwards Lifesciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Henry Schein	4 Very Positive mention(s)	1 Positive mention(s)	9 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Edwards Lifesciences	18 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Edwards Lifesciences has lower revenue, but higher earnings than Henry Schein. Henry Schein is trading at a lower price-to-earnings ratio than Edwards Lifesciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Henry Schein	$13.38B	0.73	$398M	$3.31	25.91
Edwards Lifesciences	$6.07B	8.18	$1.07B	$1.74	49.52

Edwards Lifesciences has a net margin of 15.43% compared to Henry Schein's net margin of 2.95%. Edwards Lifesciences' return on equity of 15.85% beat Henry Schein's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Henry Schein	2.95%	15.44%	5.53%
Edwards Lifesciences	15.43%	15.85%	12.14%

96.6% of Henry Schein shares are held by institutional investors. Comparatively, 79.5% of Edwards Lifesciences shares are held by institutional investors. 0.9% of Henry Schein shares are held by company insiders. Comparatively, 0.3% of Edwards Lifesciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Henry Schein has a beta of 0.81, meaning that its stock price is 19% less volatile than the broader market. Comparatively, Edwards Lifesciences has a beta of 0.86, meaning that its stock price is 14% less volatile than the broader market.

Summary

Edwards Lifesciences beats Henry Schein on 12 of the 16 factors compared between the two stocks.

How does Edwards Lifesciences compare to AMN Healthcare Services?

AMN Healthcare Services (NYSE:AMN) and Edwards Lifesciences (NYSE:EW) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, valuation, media sentiment, analyst recommendations, institutional ownership, profitability and earnings.

Edwards Lifesciences has higher revenue and earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Edwards Lifesciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AMN Healthcare Services	$2.73B	0.48	-$95.70M	-$0.87	N/A
Edwards Lifesciences	$6.07B	8.18	$1.07B	$1.74	49.52

In the previous week, Edwards Lifesciences had 14 more articles in the media than AMN Healthcare Services. MarketBeat recorded 23 mentions for Edwards Lifesciences and 9 mentions for AMN Healthcare Services. Edwards Lifesciences' average media sentiment score of 1.25 beat AMN Healthcare Services' score of 0.83 indicating that Edwards Lifesciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AMN Healthcare Services	5 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Edwards Lifesciences	18 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

AMN Healthcare Services has a beta of 0.41, meaning that its stock price is 59% less volatile than the broader market. Comparatively, Edwards Lifesciences has a beta of 0.86, meaning that its stock price is 14% less volatile than the broader market.

Edwards Lifesciences has a net margin of 15.43% compared to AMN Healthcare Services' net margin of -0.95%. AMN Healthcare Services' return on equity of 18.01% beat Edwards Lifesciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AMN Healthcare Services	-0.95%	18.01%	5.19%
Edwards Lifesciences	15.43%	15.85%	12.14%

99.2% of AMN Healthcare Services shares are held by institutional investors. Comparatively, 79.5% of Edwards Lifesciences shares are held by institutional investors. 1.1% of AMN Healthcare Services shares are held by insiders. Comparatively, 0.3% of Edwards Lifesciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

AMN Healthcare Services presently has a consensus price target of $29.00, suggesting a potential downside of 14.05%. Edwards Lifesciences has a consensus price target of $100.27, suggesting a potential upside of 16.36%. Given Edwards Lifesciences' stronger consensus rating and higher probable upside, analysts clearly believe Edwards Lifesciences is more favorable than AMN Healthcare Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AMN Healthcare Services	2 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.22
Edwards Lifesciences	0 Sell rating(s)	6 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.74

Summary

Edwards Lifesciences beats AMN Healthcare Services on 13 of the 16 factors compared between the two stocks.

How does Edwards Lifesciences compare to Abbott Laboratories?

Abbott Laboratories (NYSE:ABT) and Edwards Lifesciences (NYSE:EW) are both large-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, media sentiment, institutional ownership, analyst recommendations, profitability, valuation, earnings and risk.

Edwards Lifesciences has a net margin of 15.43% compared to Abbott Laboratories' net margin of 11.65%. Abbott Laboratories' return on equity of 17.69% beat Edwards Lifesciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Abbott Laboratories	11.65%	17.69%	9.44%
Edwards Lifesciences	15.43%	15.85%	12.14%

Abbott Laboratories currently has a consensus target price of $118.17, suggesting a potential upside of 11.50%. Edwards Lifesciences has a consensus target price of $100.27, suggesting a potential upside of 16.36%. Given Edwards Lifesciences' higher possible upside, analysts plainly believe Edwards Lifesciences is more favorable than Abbott Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Abbott Laboratories	1 Sell rating(s)	3 Hold rating(s)	19 Buy rating(s)	3 Strong Buy rating(s)	2.92
Edwards Lifesciences	0 Sell rating(s)	6 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.74

75.2% of Abbott Laboratories shares are held by institutional investors. Comparatively, 79.5% of Edwards Lifesciences shares are held by institutional investors. 0.5% of Abbott Laboratories shares are held by company insiders. Comparatively, 0.3% of Edwards Lifesciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Abbott Laboratories has higher revenue and earnings than Edwards Lifesciences. Abbott Laboratories is trading at a lower price-to-earnings ratio than Edwards Lifesciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Abbott Laboratories	$44.33B	4.14	$6.52B	$3.09	34.30
Edwards Lifesciences	$6.07B	8.18	$1.07B	$1.74	49.52

In the previous week, Abbott Laboratories had 31 more articles in the media than Edwards Lifesciences. MarketBeat recorded 54 mentions for Abbott Laboratories and 23 mentions for Edwards Lifesciences. Edwards Lifesciences' average media sentiment score of 1.25 beat Abbott Laboratories' score of 1.11 indicating that Edwards Lifesciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Abbott Laboratories	36 Very Positive mention(s)	5 Positive mention(s)	5 Neutral mention(s)	4 Negative mention(s)	1 Very Negative mention(s)	Positive
Edwards Lifesciences	18 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Abbott Laboratories has a beta of 0.61, meaning that its stock price is 39% less volatile than the broader market. Comparatively, Edwards Lifesciences has a beta of 0.86, meaning that its stock price is 14% less volatile than the broader market.

Summary

Abbott Laboratories beats Edwards Lifesciences on 9 of the 17 factors compared between the two stocks.

How does Edwards Lifesciences compare to Stryker?

Stryker (NYSE:SYK) and Edwards Lifesciences (NYSE:EW) are both large-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, institutional ownership, analyst recommendations, profitability, risk and earnings.

77.1% of Stryker shares are owned by institutional investors. Comparatively, 79.5% of Edwards Lifesciences shares are owned by institutional investors. 4.6% of Stryker shares are owned by company insiders. Comparatively, 0.3% of Edwards Lifesciences shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Stryker currently has a consensus target price of $387.88, indicating a potential upside of 18.83%. Edwards Lifesciences has a consensus target price of $100.27, indicating a potential upside of 16.36%. Given Stryker's stronger consensus rating and higher probable upside, equities analysts plainly believe Stryker is more favorable than Edwards Lifesciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Stryker	0 Sell rating(s)	5 Hold rating(s)	17 Buy rating(s)	1 Strong Buy rating(s)	2.83
Edwards Lifesciences	0 Sell rating(s)	6 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.74

Stryker has higher revenue and earnings than Edwards Lifesciences. Stryker is trading at a lower price-to-earnings ratio than Edwards Lifesciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Stryker	$25.27B	4.95	$3.25B	$9.65	33.82
Edwards Lifesciences	$6.07B	8.18	$1.07B	$1.74	49.52

In the previous week, Stryker had 35 more articles in the media than Edwards Lifesciences. MarketBeat recorded 58 mentions for Stryker and 23 mentions for Edwards Lifesciences. Edwards Lifesciences' average media sentiment score of 1.25 beat Stryker's score of 0.90 indicating that Edwards Lifesciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Stryker	28 Very Positive mention(s)	8 Positive mention(s)	15 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Edwards Lifesciences	18 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Edwards Lifesciences has a net margin of 15.43% compared to Stryker's net margin of 14.43%. Stryker's return on equity of 24.06% beat Edwards Lifesciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Stryker	14.43%	24.06%	11.45%
Edwards Lifesciences	15.43%	15.85%	12.14%

Stryker has a beta of 0.77, meaning that its share price is 23% less volatile than the broader market. Comparatively, Edwards Lifesciences has a beta of 0.86, meaning that its share price is 14% less volatile than the broader market.

Summary

Stryker beats Edwards Lifesciences on 9 of the 16 factors compared between the two stocks.

How does Edwards Lifesciences compare to Intuitive Surgical?

Edwards Lifesciences (NYSE:EW) and Intuitive Surgical (NASDAQ:ISRG) are both large-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, media sentiment, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings.

79.5% of Edwards Lifesciences shares are owned by institutional investors. Comparatively, 83.6% of Intuitive Surgical shares are owned by institutional investors. 0.3% of Edwards Lifesciences shares are owned by insiders. Comparatively, 0.6% of Intuitive Surgical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Intuitive Surgical has a net margin of 28.45% compared to Edwards Lifesciences' net margin of 15.43%. Intuitive Surgical's return on equity of 16.91% beat Edwards Lifesciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Edwards Lifesciences	15.43%	15.85%	12.14%
Intuitive Surgical	28.45%	16.91%	14.83%

Edwards Lifesciences currently has a consensus target price of $100.27, suggesting a potential upside of 16.36%. Intuitive Surgical has a consensus target price of $509.02, suggesting a potential upside of 44.06%. Given Intuitive Surgical's higher possible upside, analysts plainly believe Intuitive Surgical is more favorable than Edwards Lifesciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Edwards Lifesciences	0 Sell rating(s)	6 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.74
Intuitive Surgical	1 Sell rating(s)	8 Hold rating(s)	20 Buy rating(s)	0 Strong Buy rating(s)	2.66

Intuitive Surgical has higher revenue and earnings than Edwards Lifesciences. Intuitive Surgical is trading at a lower price-to-earnings ratio than Edwards Lifesciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Edwards Lifesciences	$6.07B	8.18	$1.07B	$1.74	49.52
Intuitive Surgical	$10.06B	12.40	$2.86B	$8.73	40.47

Edwards Lifesciences has a beta of 0.86, suggesting that its share price is 14% less volatile than the broader market. Comparatively, Intuitive Surgical has a beta of 1.46, suggesting that its share price is 46% more volatile than the broader market.

In the previous week, Intuitive Surgical had 28 more articles in the media than Edwards Lifesciences. MarketBeat recorded 51 mentions for Intuitive Surgical and 23 mentions for Edwards Lifesciences. Edwards Lifesciences' average media sentiment score of 1.25 beat Intuitive Surgical's score of 1.05 indicating that Edwards Lifesciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Edwards Lifesciences	18 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Intuitive Surgical	37 Very Positive mention(s)	1 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive

Summary

Intuitive Surgical beats Edwards Lifesciences on 13 of the 16 factors compared between the two stocks.

Get Edwards Lifesciences News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

EW vs. The Competition

Export

Metric	Edwards Lifesciences	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$49.56B	$5.67B	$7.16B	$23.68B
Dividend Yield	N/A	1.79%	2.59%	4.22%
P/E Ratio	49.52	23.11	282.25	31.00
Price / Sales	8.18	43.22	583.24	19.07
Price / Cash	30.18	32.07	71.23	31.30
Price / Book	4.84	6.31	11.09	4.62
Net Income	$1.07B	$148.76M	$3.50B	$1.07B
7 Day Performance	4.23%	1.77%	-0.24%	0.35%
1 Month Performance	-8.63%	4.58%	-3.70%	-0.55%
1 Year Performance	8.67%	2.38%	61.98%	19.21%

Edwards Lifesciences Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
EW Edwards Lifesciences	4.2284 of 5 stars	$86.17 -0.9%	$100.27 +16.4%	+8.7%	$49.56B	$6.07B	49.52	16,000	News Coverage Positive News Analyst Forecast
HSIC Henry Schein	3.4013 of 5 stars	$84.61 -1.0%	$88.62 +4.7%	+26.1%	$9.74B	$13.18B	25.56	25,000	News Coverage Positive News Upcoming Earnings Analyst Forecast
AMN AMN Healthcare Services	1.9383 of 5 stars	$33.31 +1.3%	$29.00 -12.9%	+89.3%	$1.28B	$2.73B	N/A	2,664	News Coverage Upcoming Earnings Analyst Downgrade
ABT Abbott Laboratories	4.5823 of 5 stars	$104.61 +1.5%	$118.61 +13.4%	-16.8%	$179.51B	$44.33B	33.85	115,000	Trending News Analyst Forecast Analyst Revision
SYK Stryker	4.9229 of 5 stars	$337.31 +2.1%	$392.52 +16.4%	-13.8%	$126.60B	$25.12B	39.04	56,000	Trending News Earnings Report Analyst Forecast Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:EW) was last updated on 8/2/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Edwards Lifesciences (EW) Competitors

EW vs. HSIC, AMN, ABT, SYK, and ISRG

How does Edwards Lifesciences compare to Henry Schein?

Summary

How does Edwards Lifesciences compare to AMN Healthcare Services?

Summary

How does Edwards Lifesciences compare to Abbott Laboratories?

Summary

How does Edwards Lifesciences compare to Stryker?

Summary

How does Edwards Lifesciences compare to Intuitive Surgical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EW vs. The Competition

Edwards Lifesciences Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Edwards Lifesciences (EW) Competitors

EW vs. HSIC, AMN, ABT, SYK, and ISRG

How does Edwards Lifesciences compare to Henry Schein?

Do analysts prefer HSIC or EW?

Does the media prefer HSIC or EW?

Which has preferable earnings and valuation, HSIC or EW?

Is HSIC or EW more profitable?

Do insiders and institutionals hold more shares of HSIC or EW?

Which has more volatility and risk, HSIC or EW?

Summary

How does Edwards Lifesciences compare to AMN Healthcare Services?

Which has stronger earnings & valuation, AMN or EW?

Does the media prefer AMN or EW?

Which has more risk & volatility, AMN or EW?

Is AMN or EW more profitable?

Do insiders & institutionals hold more shares of AMN or EW?

Do analysts prefer AMN or EW?

Summary

How does Edwards Lifesciences compare to Abbott Laboratories?

Is ABT or EW more profitable?

Do analysts rate ABT or EW?

Do institutionals & insiders believe in ABT or EW?

Which has stronger earnings and valuation, ABT or EW?

Does the media prefer ABT or EW?

Which has more volatility and risk, ABT or EW?

Summary

How does Edwards Lifesciences compare to Stryker?

Do insiders and institutionals believe in SYK or EW?

Do analysts rate SYK or EW?

Which has higher earnings & valuation, SYK or EW?

Does the media prefer SYK or EW?

Is SYK or EW more profitable?

Which has more risk and volatility, SYK or EW?

Summary

How does Edwards Lifesciences compare to Intuitive Surgical?

Do insiders & institutionals hold more shares of EW or ISRG?

Is EW or ISRG more profitable?

Do analysts rate EW or ISRG?

Which has better valuation & earnings, EW or ISRG?

Which has more volatility and risk, EW or ISRG?

Does the media refer more to EW or ISRG?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EW vs. The Competition

Edwards Lifesciences Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools